SUPPORT AND MANAGEMENT IN TOXICOLOGY
At InnVitro, we have the best solutions to support toxicology applied to human, animal, and environmental health.
Our internationally specialized team is prepared to help you meet regulatory demands and ensure the safety and efficacy of your products.
Every project is customer-tailored with an innovative perspective built upon science and quality.
Our international technical staff uses cutting-edge solutions from the scientific market, bringing solutions and offering reliable support with agility and efficacy, saving time and investments for your business.
Contact us now and bring you the best solution for your demand.
WHO WE ARE
TEAM
Degree in Biology, Master's degree and Ph.D. in Cellular and Molecular Biology, Visit Research Fellow (Post Doc) at the Molecular Toxicology group at the University of Surrey, Guildford, UK, Diplomate of the American Board of Toxicology (2022). Formal training ins ISO17025 and GLP.
She is an experienced toxicologist with more than 400 projects in diverse industries: Pharmaceutical, Medical Devices, Food, Cosmetics, Agrochemicals, Sanitizing Products, and Veterinary. She has given lectures and courses in-company and at technical entities such as ANVISA, RENAME, MUTAGen Brasil, SBTox, SINDUSFARMA, and SINDIVEG. As a technical inspector, she accumulates more than 1200 hours of inspection (INMETRO - National accreditation institute, and Rede Metrológica do Rio Grande do Sul - State accreditation institute).
Active participant in technical groups to discuss technical guides related to product safety. Part of RENAME (Brazilian Network of Alternative Methods) since foundation. Invited specialist to coordinate Premasul (Mercosul platform of alternative methods) courses and as consultant at the INMETRO interlaboratory study for the in vitro micronucleus assay.
Izabel Vianna Villela, PhD, DABT
EXECUTIVE
DIRECTOR
Degree in Pharmacy and Biochemistry, Master’s degree in Biophysics, Docteur D’Etat es Sciences Naturelles - Institut Curie, France, Post- Doctoral fellowship at Institut für Mikrobiologie, J.W. Goethe Universität - Frankfurt, Germany.
He is a University Professor, a member of the Brazilian Academy of Sciences, and founder of the pioneer laboratory in providing genotoxicity and cytotoxicity services under GLP conditions in Brazil.
He is also a researcher, level IA – CNPq, and "ad hoc" consultant for several entities.
He is an advisor for government agencies such as CNPq, CAPES, Brazil's two federal scientific agencies, and MCTI (Federal Ministry of Science, Technology, and Innovation).
He has authored and co-authored more than 400 scientific articles, reviews, and book chapters published.
He has vast experience in government agencies, CNPq, CAPES, MCTIC, was the first president of MutaGen Brazil, was the National Director of CBAB, and is a former President of FAPERGS.
João Antonio Pêgas Henriques, PhD
SCIENTIFIC DIRECTOR
Degree in Biology, Master's degree in Ecology. RAHE fellow in preclinical evaluation in vitro trials under GLP condition (Basel, Switzerland).
She has training in ISO/IEC 17025 quality and Good Laboratory Practices - GLP.
She has years of experience in managing a Test Unit dedicated to genotoxicity and cytotoxicity monitored by the CGCRE in Good Laboratory Practices - GLP and is experienced in implementing the GLP quality system. She has been a Quality Inspector (Rede Metrológica do Rio Grande do Sul - State accreditation institute) since 2009.
Miriam Benicio da Fonseca, MsC
OPERATIONAL DIRECTOR
Degree in Pharmacy, Master's degree in Molecular and Cellular Biology, Ph.D. in Biologic Sciences - Biochemistry with a doctoral stage in Paris (France) by a French-Brazilian fellow research network CAPES-COFECUB. Post-doctoral Fellowship at UFRGS, Brazil by a Brazil-UK research network. Training in GLP and Regulatory Affairs and ANVISA Drug Registration.
She has integrated national and international projects in the toxicology of natural and synthetic products, focusing on cytotoxicity, mutagenicity, and DNA repair. She has published scientific articles in international scientific journals.
With extensive experience in the market, she has worked in implementing and executing in vitro tests on GLP for the toxicological evaluation of products for regulatory purposes. She has participated in product risk assessment projects with pharmaceutical, cosmetic, health products, and agrochemical industries.
Miriana da Silva Machado, PhD
TECHNICAL
DIRECTOR
CLIENTS AND PARTNERS
We founded InnVitro intending to use all our international scientific knowledge and expertise to search for solutions in toxicology support, and toxicology management for our customers. Our expertise relies on a solid scientific background, extensive technical experience, and experience in interacting with the productive sector. At InnVitro, we meet the most challenging needs of the market in toxicological safety assessment.
In years in the market, we have provided high levels of satisfaction to customers from various segments within the national and international industry.
HISTORY
OUR DIFFERENTIAL
MISSION, VISION, and VALUES
MISSION
To transform scientific knowledge into innovative solutions for technological development, aiming at health and well-being.
VISION
To be a leader in in vitro strategies and innovation for the technological and scientific development of our clients.
VALUES
We will conduct our business with the highest standards of ethics, integrity, quality, respect, and scientific rigor.